Article Details

Mar 27,2025 | Chugai Obtains Regulatory Approval for First Tablet for SMA, Evrysdi | News

Retrieved on: 2025-03-27 14:00:56

Tags for this article:

Click the tags to see associated articles and topics

Mar 27,2025 | Chugai Obtains Regulatory Approval for First Tablet for SMA, Evrysdi | News. View article details on hiswai:

Excerpt

Roche leads the clinical development of Evrysdi as part of a collaboration with the SMA Foundation and PTC Therapeutics. About Evrysdi Evrysdi is a ...

Article found on: www.chugai-pharm.co.jp

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo